v3.26.1
Balance Sheet Components
 3 Months Ended
Mar. 31, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Balance Sheet Components Balance Sheet Components
Prepaid and Other Current Assets
Prepaid and other current assets consisted of the following (in thousands):
March 31,
2026		December 31,
2025
Prepaid research and development contract services$563 $115 
Advanced professional fees319 193 
Prepaid insurance208 367 
Other prepaid expenses and other current assets162 73 
Total prepaid and other current assets$1,252 $748 
Property and Equipment, Net
Property and equipment, net was comprised of the following (in thousands):
March 31,
2026		December 31,
2025
Equipment
$1,661 $1,661 
Furniture and fixtures
258 258 
Leasehold improvements
132 132 
Total property and equipment
2,051 2,051 
Less: accumulated depreciation
(1,802)(1,756)
Property and equipment, net
$249 $295 
Depreciation expense for the three months ended March 31, 2026 was an immaterial amount. For the three months ended March 31, 2025, depreciation expense was $0.1 million.
Other long-term prepaid assets
Other long-term prepaid assets consisted of the advance payments for clinical trial services, totaling $1.0 million and $0.8 million for March 31, 2026 and December 31, 2025, respectively.
Accrued Expenses
Accrued expenses consisted of the following (in thousands):
March 31,
2026		December 31,
2025
Accrued professional fees$623 $818 
Accrued compensation and benefits833 2,528 
Accrued clinical trial and research and development costs
3,345 2,298 
Accrued interest1,080 741 
Other accrued expenses34 42 
Total accrued expenses
$5,915 $6,427